Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,661,351
+$230,396 QoQ
Shares Held
10,479
+5.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.25%
of 13F equity value
Holder Rank
#2,096
of 4,676 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARSHALL INVESTMENT MANAGEMENT, LLC holds $10,842,412 across 9 Drug Manufacturers - General names. JNJ ranks #3 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,220 | $5,061,595 | |
| 2 | AMGN |
Amgen Inc
|
8,386 | $3,036,738 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
10,479 | $2,661,351 | |
| 4 | MRK |
Merck & Co., Inc.
|
500 | $64,250 | |
| 5 | NVS |
Novartis AG
|
51 | $7,992 | |
| 6 | NVO |
Novo Nordisk A S
|
103 | $4,937 | |
| 7 | AZN |
Astrazeneca PLC
|
19 | $3,602 | |
| 8 | SNY |
Sanofi
|
26 | $1,109 |
All Filings in JNJ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,661,351 | 10,479 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,430,955 | 9,945 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,035,560 | 9,836 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,696,593 | 9,150 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,459,723 | 8,802 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,171,277 | 8,099 | Shares | Sole | 2025-02-04 | |
| No filing history on record for this holder in this stock. | ||||||